EUPRAXIA PHARMACEUTICALS INC. Financing Cash Flow
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Financing Cash Flow of $76.06 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-03-13
| Period end | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|
| 2025-12-31 | $76.06M 40-F · filed 2026-03-13 | |
| 2024-12-31 | $45.78M 40-F · filed 2026-03-13 | |
| 2023-12-31 | $21.08M 40-F · filed 2025-03-20 | $21.01M 40-F · filed 2024-04-01 |
| 2022-12-31 | $10.80M 40-F · filed 2024-04-01 |